DK1399144T3 - Carbamatforbindelser til anvendelse ved forebyggelse eller behandling af angstforstyrrelser - Google Patents

Carbamatforbindelser til anvendelse ved forebyggelse eller behandling af angstforstyrrelser

Info

Publication number
DK1399144T3
DK1399144T3 DK02759750T DK02759750T DK1399144T3 DK 1399144 T3 DK1399144 T3 DK 1399144T3 DK 02759750 T DK02759750 T DK 02759750T DK 02759750 T DK02759750 T DK 02759750T DK 1399144 T3 DK1399144 T3 DK 1399144T3
Authority
DK
Denmark
Prior art keywords
group
anxiety disorders
phenyl
alkyl
prevention
Prior art date
Application number
DK02759750T
Other languages
Danish (da)
English (en)
Inventor
Carlos R Plata-Salaman
Roy E Twyman
Boyu Zhao
Original Assignee
Ortho Mcneil Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho Mcneil Pharm Inc filed Critical Ortho Mcneil Pharm Inc
Application granted granted Critical
Publication of DK1399144T3 publication Critical patent/DK1399144T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/325—Carbamic acids; Thiocarbamic acids; Anhydrides or salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Psychiatry (AREA)
  • Anesthesiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
DK02759750T 2001-02-27 2002-02-21 Carbamatforbindelser til anvendelse ved forebyggelse eller behandling af angstforstyrrelser DK1399144T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US27168901P 2001-02-27 2001-02-27

Publications (1)

Publication Number Publication Date
DK1399144T3 true DK1399144T3 (da) 2006-07-24

Family

ID=23036639

Family Applications (1)

Application Number Title Priority Date Filing Date
DK02759750T DK1399144T3 (da) 2001-02-27 2002-02-21 Carbamatforbindelser til anvendelse ved forebyggelse eller behandling af angstforstyrrelser

Country Status (25)

Country Link
US (3) US7078436B2 (de)
EP (1) EP1399144B1 (de)
JP (1) JP2004523554A (de)
KR (1) KR20030078947A (de)
CN (1) CN1503665A (de)
AT (1) ATE324107T1 (de)
AU (1) AU2002306567B2 (de)
BR (1) BR0207830A (de)
CA (1) CA2439286A1 (de)
CY (1) CY1107468T1 (de)
CZ (1) CZ20032311A3 (de)
DE (1) DE60210960T2 (de)
DK (1) DK1399144T3 (de)
ES (1) ES2262826T3 (de)
HU (1) HUP0303262A2 (de)
IL (1) IL157594A0 (de)
MX (1) MXPA03007720A (de)
MY (1) MY136391A (de)
NO (1) NO20033800L (de)
NZ (1) NZ546549A (de)
PL (1) PL364639A1 (de)
PT (1) PT1399144E (de)
RS (1) RS50505B (de)
RU (1) RU2292881C2 (de)
WO (1) WO2002067923A1 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2262826T3 (es) * 2001-02-27 2006-12-01 Ortho-Mcneil Pharmaceutical, Inc. Uso de un compuesto de carbamato en la prevencion o el tratamiento de transtornos de ansiedad.
EP1850841A1 (de) 2005-01-20 2007-11-07 Janssen Pharmaceutica N.V. Verfahren zur qt-intervall-steuerung
ES2435403T3 (es) 2005-06-08 2013-12-19 Sk Biopharmaceuticals Co., Ltd. Tratamiento de trastornos del sueño y vigilia
MX2009004552A (es) * 2006-10-27 2009-11-10 Janssen Pharmaceutica Nv Metodos de tratamiento de trastornos de comportamiento perturbador.
US8263652B2 (en) * 2007-10-31 2012-09-11 Sk Biopharmaceuticals Co., Ltd. Stabilized pediatric suspension of carisbamate
US8609849B1 (en) 2010-11-30 2013-12-17 Fox Chase Chemical Diversity Center, Inc. Hydroxylated sulfamides exhibiting neuroprotective action and their method of use
EP2968210B1 (de) * 2013-03-12 2024-09-11 Bio-Pharm Solutions Co., Ltd. Phenylcarbamatverbindungen zur verwendung in der vorbeugung oder behandlung pädiatrischer epilepsie
US9566261B2 (en) 2013-03-12 2017-02-14 Bio-Pharm Solutions Co., Ltd. Phenyl carbamate compound and a composition for preventing or treating a memory loss-related disease comprising the same
ES3059582T3 (en) * 2016-02-29 2026-03-23 Bio Pharm Solutions Co Ltd Sulfamate derivative compounds, processes for preparing them and their uses
US10195151B2 (en) 2016-09-06 2019-02-05 Jazz Pharmaceuticals International Iii Limited Formulations of (R)-2-amino-3-phenylpropyl carbamate
KR102900173B1 (ko) * 2016-12-14 2025-12-12 에스케이바이오팜 주식회사 조현병, 강박장애 및 투렛증후군으로부터 선택되는 정신증 장애의 예방, 경감 또는 치료에 있어서의 카바메이트 화합물의 용도
AU2018278332B2 (en) 2017-06-02 2022-05-19 Jazz Pharmaceuticals Ireland Limited Methods and compositions for treating excessive sleepiness
US10940133B1 (en) 2020-03-19 2021-03-09 Jazz Pharmaceuticals Ireland Limited Methods of providing solriamfetol therapy to subjects with impaired renal function

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3313692A (en) 1958-04-21 1967-04-11 Armour Pharma Method of inducing calming and muscle relaxation with carbamates
US3278380A (en) * 1962-02-06 1966-10-11 Armour Pharma Methods of calming employing diphenyl hydroxy carbamate compounds
US3248418A (en) 1962-06-26 1966-04-26 Charles D Bossinger 2-hydroxy-2-phenyl alkyl carbamates
US3265728A (en) 1962-07-18 1966-08-09 Armour Pharma Substituted phenethyl carbamates
CN1109880A (zh) * 1994-02-03 1995-10-11 合成实验室公司 3-(2-氨基乙基)-4-[3-(三氟甲基)苯甲酰基]-3，4-二氢-2h-1，4-苯并噁嗪衍生物、制备及其应用
US5698588A (en) * 1996-01-16 1997-12-16 Yukong Limited Halogen substituted carbamate compounds from 2-phenyl-1,2-ethanediol
MXPA03007717A (es) 2001-02-27 2005-11-08 Johnson & Johnson Compuestos de carbamato para su uso en la prevencion o tratamiento de trastornos bipolares.
ES2262826T3 (es) * 2001-02-27 2006-12-01 Ortho-Mcneil Pharmaceutical, Inc. Uso de un compuesto de carbamato en la prevencion o el tratamiento de transtornos de ansiedad.
US6541513B2 (en) 2001-02-27 2003-04-01 Ortho-Mcneil Pharmaceutical, Inc. Carbamate compounds for use in preventing or treating psychotic disorders

Also Published As

Publication number Publication date
PT1399144E (pt) 2006-07-31
YU67903A (sh) 2006-08-17
CN1503665A (zh) 2004-06-09
NZ546549A (en) 2007-11-30
BR0207830A (pt) 2004-06-22
MY136391A (en) 2008-09-30
US7078436B2 (en) 2006-07-18
JP2004523554A (ja) 2004-08-05
KR20030078947A (ko) 2003-10-08
MXPA03007720A (es) 2004-11-12
AU2002306567B2 (en) 2006-08-17
NO20033800L (no) 2003-09-26
RU2292881C2 (ru) 2007-02-10
IL157594A0 (en) 2004-03-28
HUP0303262A2 (hu) 2004-01-28
DE60210960T2 (de) 2006-11-16
ATE324107T1 (de) 2006-05-15
EP1399144A1 (de) 2004-03-24
CZ20032311A3 (cs) 2005-02-16
US20090234003A1 (en) 2009-09-17
DE60210960D1 (de) 2006-06-01
EP1399144B1 (de) 2006-04-26
US20020143053A1 (en) 2002-10-03
ES2262826T3 (es) 2006-12-01
WO2002067923A1 (en) 2002-09-06
HK1062270A1 (en) 2004-10-29
RS50505B (sr) 2010-03-02
CY1107468T1 (el) 2012-12-19
US20050267203A1 (en) 2005-12-01
PL364639A1 (en) 2004-12-13
RU2003128986A (ru) 2005-03-20
NO20033800D0 (no) 2003-08-26
CA2439286A1 (en) 2002-09-06

Similar Documents

Publication Publication Date Title
MY157373A (en) Carbamate compounds for use in preventing or treating movement disorders
MY138156A (en) Carbamate compounds for use in preventing or treating neurodegenerative disorders
DK1408953T3 (da) Carbamatforbindelser til anvendelse til forebyggelse eller behandling af bipolær sygdom
DK1399144T3 (da) Carbamatforbindelser til anvendelse ved forebyggelse eller behandling af angstforstyrrelser
DK1368021T3 (da) Carbamatforbindelser til anvendelse ved forebyggelse eller behandling af bipolær sygdom
EA200700642A1 (ru) Способы лечения эпилептогенеза и эпилепсии
MY129312A (en) Carbamate compounds for use in the treatment of pain
DK1305082T3 (da) Carbamatforbindelser til anvendelse til forebyggelse eller behandling af neuropatisk smerte og klynge- eller migrænehovedpine-associeret smerte
DK1408954T3 (da) Carbamatforbindelser til anvendelse ved forebyggelse eller behandling af neuropatisk smerte
MY136733A (en) Carbamate compounds for use in preventing or treating psychotic disorders
MY136347A (en) Carbamate compounds for use in preventing or treating neuropathic pain and cluster and migraine headache-associated pain